Navigation Links
Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
Date:7/21/2009

s is an important new position for our Company and is reflective of the continued evolution of Novavax in the vaccine space. John brings a unique blend of skills in vaccine product positioning strategy, government relations, and commercial markets to augment our existing management team to capitalize on the new opportunities available to the Company."

Mr. Trizzino is a graduate of Long Island University and received his master's degree in business administration from New York University's Stern School of Business.

About Novavax

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Novavax Announces Repayment of $5 Million of Convertible Debt
2. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
3. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
4. Novavax Appoints Stanley Erck to Board of Directors
5. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
6. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009
7. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
8. Novavax Reports First Quarter 2009 Financial Results
9. Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate
10. Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call
11. Novavax Announces Early Retirement of $17 Million of Convertible Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 Yuma Regional ... and complementary therapies brings comprehensive cancer care to ... Yuma Regional Cancer Center has officially opened. A ... program includes services such as open, semi-private and ... American Cancer Society Resource Center, hematology, rehabilitation center, ...
(Date:7/30/2014)... Md. , July 30, 2014 ... components to interrogate biology, but such devices can ... As such, researchers have looked ... in vitro metabolic engineering to characterize ... a chip. New devices are envisioned to recreate ...
(Date:7/30/2014)... , July 30, 2014  RXi Pharmaceuticals ... biotechnology company focused on discovering, developing and ... needs using RNA-targeted technologies, today announced that ... RXI-109, for the reduction of recurrence of ... has been initiated. Logo - ...
(Date:7/30/2014)... San Diego, CA (PRWEB) July 30, 2014 ... second contract from the U.S. Environmental Protection Agency ... company’s expertise in developmental toxicity models, including tests ... on neuron formation and the formation of connections ... function. Inhibition of neurodifferentiation and synapse formation by ...
Breaking Biology Technology:Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3
... than a Thousand Submissions Already Received for the ... USCAMBRIDGE, Mass., Jan. 15 The Nano Science ... and Sustainable Industries Organization (CTSI), today announced that ... the largest Cleantechnology, Biotechnology and Nanotechnology event in ...
... 15 The Court of ... found Boston Scientific Corporation,s Ding patent invalid, and reversed ... Coronary Stent infringed that patent. Cordis is very pleased ... rendered in July 2005 in Wilmington, Delaware. The ...
... have entered into a research collaboration to improve insect control in ... ... Research Triangle Park, NC (Vocus) January 15, 2009 -– DuPont and ... improve insect control in corn and soybeans. Under the agreement, ...
Cached Biology Technology:TechConnect World 2009 Announces January 28th 'Last Call' for Speaker-Proposals 2TechConnect World 2009 Announces January 28th 'Last Call' for Speaker-Proposals 3DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 2DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 3
(Date:7/30/2014)... Chemical Society (ACS) announced today that David L. Kaplan, ... Biomaterials Science & Engineering as editor-in-chief. With the ... new journal will feature high-quality research in the rapidly ... naturally derived materials that interact with living or biological ... reflects the tremendous growth in the field of biomaterials ...
(Date:7/30/2014)... Institute (SALSI), a joint venture between The University of ... Texas Health Science Center at San Antonio, has selected ... winners, Emily Boice from UTSA and Lei Huang from ... project titled, "Novel engineered ferritins for tracking and protecting ... Huang,s research is focused on finding a treatment for ...
(Date:7/30/2014)... HIV infection could be as simple as inserting a ... University of Washington bioengineers have discovered a potentially faster ... from contracting HIV. Their method spins the drug into ... moisture, releasing higher doses of the drug than possible ... , "This could offer women a potentially more effective, ...
Breaking Biology News(10 mins):ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
... release is available in Spanish . ... acids and they play a fundamental role in all of ... they, therefore, carry out numerous functions in an organism: immunological ... (they form part of enzymes) and a long list of ...
... hold promise for improved early disease screening, cancer staging, therapeutic ... Ge Wang , director of Virginia Tech,s Center for ... the refereed journal PLOS ONE . , ... framework "is a new way of thinking in the biomedical ...
... prepping for a hurricane, the bacterium Bacillus subtilis ... times. In a new study, scientists at Rice University and ... B. subtilis to begin preparing for survival, even ... down" and withdraw into a hardened spore. The new ...
Cached Biology News:Using computational biology for the annotation of proteins 2Using computational biology for the annotation of proteins 3Scanning innovation can improve personalized medicine 2Scanning innovation can improve personalized medicine 3Deciphering bacterial doomsday decisions 2Deciphering bacterial doomsday decisions 3
...
... Kit is an advanced system for isolating DNA from ... be used directly for any downstream application. ... to use in 56 minutes Low melting point ... and TBE gels No specialised equipment required ...
... Spin Columns provide a rapid and simple method ... bp to 10 kb) from stained agarose gels ... excised from an agarose gel and loaded into ... the column are a series of membranes and ...
... Kit has been designed for recovery of DNA from ... Features Ultra fast protocol: DNA is ready ... are easy to resuspend Bead uniformity prevents shearing ... (suitable for PCR) DNA is eluted into sterile ...
Biology Products: